Organigram Global (OGI) Net Cash Flow (2018 - 2026)
Organigram Global (OGI) posted quarterly Net Cash Flow of -$349.7 million for Q1 2026, down 101.23% year-on-year from $28.3 billion in Q1 2025, and down 2243.6% on a QoQ basis from -$14.9 million in Q4 2025.
Organigram Global (OGI) Net Cash Flow (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Net Cash Flow for 7 consecutive years, with -$349.7 million the latest figure, recorded in Q1 2026.
- Quarterly Net Cash Flow fell 101.23% year-over-year to -$349.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 billion (down 1.12% YoY) and the FY2025 annual result came in at -$35.8 million, down 160.47% from the prior year.
- Net Cash Flow declined to -$349.7 million in Q1 2026 per OGI's latest filing, from -$14.9 million in the prior quarter.
- Over the last five years, Net Cash Flow for OGI reached as high as $28.3 billion in Q1 2025 and fell as low as -$349.7 million in Q1 2026.
- A 3-year average of $7.0 billion and a median of -$31.1 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow surged 68.39% — and 2026, when it sank 101.23%.
- Year by year, Net Cash Flow stood at -$47.2 million in 2024, then jumped by 68.39% to -$14.9 million in 2025, then tumbled by 2243.6% to -$349.7 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$349.7 million, -$14.9 million, and $28.3 billion for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | -349.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -349.67 Mn |
| Mar 31, 2026 | -349.67 Mn |
| Dec 31, 2025 | -14.92 Mn |
| Dec 31, 2025 | -14.92 Mn |
| Mar 31, 2025 | 28.32 Bn |
| Mar 31, 2025 | 28.32 Bn |
| Dec 31, 2024 | -47.20 Mn |
| Dec 31, 2024 | -47.20 Mn |
| May 31, 2021 | -392,000.00 |
| May 31, 2021 | -392,000.00 |
| Feb 28, 2021 | -93.46 Bn |
| Feb 28, 2021 | -93.46 Bn |
| Nov 30, 2020 | 142.51 Bn |
| Nov 30, 2020 | 142.51 Bn |
| Aug 31, 2020 | -164.84 Mn |
| Aug 31, 2020 | -164.84 Mn |
| May 31, 2020 | 2.54 Mn |
| May 31, 2020 | 2.54 Mn |
| Feb 29, 2020 | 52.66 Mn |
| Feb 29, 2020 | 52.66 Mn |